Tabulong, Janeth A.
HRN: 27-49-04 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/30/2025
08/30/2025
IV
4.5g
Now
Pleural Effusion
Checking Initial Appropriateness
08/30/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/30/2025
08/31/2025
IV
4.5
Q6
Pleural Effusion
Checking Initial Appropriateness
08/30/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/01/2025
09/05/2025
IV
2.25g
Q8
Pleural Effusion
Checking Initial Appropriateness